Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 4
2004 6
2005 3
2006 4
2007 7
2008 1
2009 6
2010 7
2011 5
2012 10
2013 8
2014 9
2015 8
2016 9
2017 8
2018 12
2019 16
2020 10
2021 13
2022 15
2023 7
2024 13
2025 11
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean jorgensen poul, H (18 results)?
MIF-CD74 signaling drives immune modulation in medulloblastoma.
Draper B, You Z, Thompson D, Guo X, Morcavallo A, Chillon Pino D, Lorenzo Gido Nery C, Shrestha S, Bowers CE, Himsworth C, Delaidelli A, Remeniuk B, Morlando S, Wade B, Gordon F, Sanchez-Corrales Y, Hopkins B, Monteiro N, Locke D, Liu M, Diaz JT, Greenslade K, Martins da Costa B, Barker K, Kwok C, Ogunbiyi O, Fletcher A, Richardson S, Custodia C, Roque R, Jackson T, Barfoot R, Castellano S, Hill RM, Saulnier O, Jacques TS, Taylor MD, Faria CC, Ayrault O, Sorensen PH, Anderson J, Chesler L, Huang LF, Clifford SC, Donovan LK. Draper B, et al. Among authors: sorensen ph. Neuro Oncol. 2026 Feb 6:noag020. doi: 10.1093/neuonc/noag020. Online ahead of print. Neuro Oncol. 2026. PMID: 41652893
Future Directions and Priorities for Cellular Therapy in Sarcoma: A Report from the Strategic Advances in Sarcoma Science Cell Therapy Breakout.
Oliva-Ramirez J, Milewski D, Banks L, Bailey KM, Moding EJ, Lake J, Chen A, Daley JD, Resch EE, Kaplan RN, Ladle BH, Zhang L, Chou MM, Nguyen R, Dagalakis U, Al Akoum N, Sorensen PH, Fletcher JA, DeMatteo R, Llosa NJ, Pollack SM. Oliva-Ramirez J, et al. Among authors: sorensen ph. Cancers (Basel). 2025 Sep 19;17(18):3068. doi: 10.3390/cancers17183068. Cancers (Basel). 2025. PMID: 41008910 Free PMC article. Review.
Protocol for plasma membrane enrichment by ultracentrifugation for mass spectrometry of cell lines, xenografts, and patient tumors.
Hamilton AK, Mooney B, Glisovic-Aplenc T, Radaoui AB, Conkrite KL, De Jong C, Sidoli S, Sorensen PH, Garcia BA, Aplenc R, Maris JM, Morin GB, Diskin SJ. Hamilton AK, et al. Among authors: sorensen ph. STAR Protoc. 2025 Sep 19;6(3):104049. doi: 10.1016/j.xpro.2025.104049. Epub 2025 Aug 29. STAR Protoc. 2025. PMID: 40884789 Free PMC article.
Endoglin-Directed CAR T Cells Comprehensively Target Tumors in Advanced Sarcomas.
Berger HR, Maharana M, Mirabal J, Kurenbekova L, Delaidelli A, Dasgupta A, Gad AZ, Sheha MF, Kerr SS, Ozcan AI, Morris JS, Major AM, Hicks MJ, McKenna MK, Seon BK, Baker ML, Sorensen PH, Hegde M, Yustein JT, Ahmed N, Joseph SK. Berger HR, et al. Among authors: sorensen ph. Cancer Immunol Res. 2025 Oct 1;13(10):1591-1608. doi: 10.1158/2326-6066.CIR-24-0897. Cancer Immunol Res. 2025. PMID: 40748238 Free PMC article.
Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.
El-Naggar AM, Somasekharan SP, Wang Y, Cheng H, Negri GL, Pan M, Wang XQ, Delaidelli A, Rafn B, Cran J, Zhang F, Zhang H, Colborne S, Gleave M, Mandinova A, Kedersha N, Hughes CS, Surdez D, Delattre O, Wang Y, Huntsman DG, Morin GB, Sorensen PH. El-Naggar AM, et al. Among authors: sorensen ph. EMBO Rep. 2025 Jun;26(12):3226-3227. doi: 10.1038/s44319-025-00478-6. EMBO Rep. 2025. PMID: 40442423 Free PMC article.
Cystathionine gamma-lyase-mediated hypoxia inducible factor 1-alpha expression drives clear cell ovarian cancer progression.
El-Naggar AM, Li Y, Turgu B, Ding Y, Wei L, Chen SY, Trigo-Gonzalez G, Kalantari F, Vallejos R, Lynch B, Senz J, Lum A, Douglas JM, Salamanca C, Thornton S, Qin Y, Parmar K, Spencer SE, Leung S, Woo MMM, Yong PJ, Zhang HF, Hughes CS, Negri GL, Wang Y, Morin GB, Sorensen PH, Huntsman DG. El-Naggar AM, et al. Among authors: sorensen ph. J Pathol. 2025 Jul;266(3):352-367. doi: 10.1002/path.6433. Epub 2025 May 15. J Pathol. 2025. PMID: 40371821 Free PMC article.
Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study.
Lin YY, Noghabi HS, Volik S, Bell R, Sar F, Haegert A, Chung HC, Fazli L, Oo HZ, Daugaard M, Kuo MH, Hsu SC, Imeda EL, Zanettini C, Queiroz L, Schlotmann B, Gheybi K, Cooper C, Kote-Jarai Z, Eeles R; Pan Prostate Cancer Group (PPCG); Kung HJ, Marchionni L, Weischenfeldt J, Miller KD, Rabinowitz A, Wang Y, Zhang HF, Sorensen PH, Carey MS, Gleave M, Hayes VM, Gibson WT, Collins CC. Lin YY, et al. Among authors: sorensen ph. medRxiv [Preprint]. 2025 Apr 29:2025.04.28.25326584. doi: 10.1101/2025.04.28.25326584. medRxiv. 2025. PMID: 40343042 Free PMC article. Preprint.
High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor.
Delaidelli A, Burwag F, Ben-Neriah S, Suk Y, Shyp T, Kosteniuk S, Dunham C, Cheng S, Okonechnikov K, Schrimpf D, von Deimling A, Ellezam B, Perreault S, Singh S, Hawkins C, Kool M, Pfister SM, Steidl C, Hughes C, Korshunov A, Sorensen PH. Delaidelli A, et al. Among authors: sorensen ph. Neuro Oncol. 2025 Oct 14;27(9):2431-2444. doi: 10.1093/neuonc/noaf046. Neuro Oncol. 2025. PMID: 40040502
186 results